ARBOR HEALTH TECHNOLOGIES INC.
PHYSICIAN COMPENSATION POLICY
Fair Market Value and Commercial Reasonableness Standards
Right-click to update Table of Contents
I. PURPOSE AND SCOPE
A. Purpose
This Physician Compensation Policy (the "Policy") establishes uniform, enterprise-wide standards to ensure that all physician compensation arrangements entered into by Arbor Health Technologies Inc. ("AHT" or the "Company") satisfy fair market value ("FMV") and commercial reasonableness requirements under applicable federal and state law. The promulgation of this Policy reflects AHT's commitment to maintaining a robust compliance infrastructure and its recognition that the integrity of physician compensation arrangements is critical to the Company's continued participation in federal healthcare programs.
Specifically, this Policy is designed to accomplish the following objectives:
1. Stark Law and Anti-Kickback Statute Compliance. Establish and document compensation-setting processes that ensure all physician compensation arrangements satisfy the requirements of the federal Physician Self-Referral Law (the "Stark Law," 42 U.S.C. § 1395nn) and the federal Anti-Kickback Statute (the "AKS," 42 U.S.C. § 1320a-7b(b)), including applicable exceptions and safe harbors thereunder.
2. Safe Harbor and Exception Compliance. Ensure that physician compensation arrangements are structured to qualify for applicable safe harbors under 42 C.F.R. § 1001.952 and Stark Law exceptions under 42 C.F.R. § 411.350 et seq., with particular attention to the employment exception (42 C.F.R. § 411.357(c)), personal services exception (42 C.F.R. § 411.357(d)), fair market value exception (42 C.F.R. § 411.357(l)), and indirect compensation arrangement exception (42 C.F.R. § 411.357(p)).
3. Modernization Rule Compliance. Ensure compliance with the CMS Stark Law Modernization Final Rule (85 Fed. Reg. 77492, effective January 19, 2021) and the AKS Safe Harbor Modernization Final Rule (85 Fed. Reg. 77684, effective January 19, 2021), including the revised definitions of FMV and commercial reasonableness codified therein, and the new value-based enterprise exceptions and safe harbors.
4. State Law Compliance. Address applicable state anti-kickback and referral fee statutes in each jurisdiction in which AHT operates, including Massachusetts General Laws Chapter 175H, Section 3 (M.G.L. c. 175H, § 3), which extends anti-kickback prohibitions to all-payer arrangements (not only federal healthcare program patients), and Connecticut General Statutes Section 20-7a(d) (Conn. Gen. Stat. § 20-7a(d)), which prohibits the payment of referral fees in connection with medical services.
5. Remediation of Identified Compliance Gaps. Respond to and remediate the specific findings and recommendations set forth in the compliance gap assessment conducted by Grayson Whitaker & Associates LLP (Report No. GW-AHT-2022-Final, dated December 12, 2022), and the self-assessment engagement conducted by Calderwood & Harkness LLP (January 30, 2023 – July 12, 2023, Matter No. 1010-00003). Those engagements identified significant deficiencies in the Company's physician compensation practices, including a lack of documented FMV substantiation for numerous arrangements, above-benchmark medical director compensation, and incomplete integration of physician compensation arrangements assumed in the Lakeview Medical Associates, P.C. acquisition.
This Policy is intended to be read and applied in conjunction with the Company's Revised Compliance Program Manual (AHT-COMPL-2023-001), the Revised Physician Referral and Self-Referral Policy, the Revised Vendor and Third-Party Arrangement Policy, and the related contract templates prepared by Calderwood & Harkness LLP. Where any conflict exists between this Policy and any prior Company policy, procedure, or practice, this Policy shall control.
B. Scope — Covered Arrangements
This Policy applies to all compensation arrangements between AHT (or any AHT subsidiary, affiliate, or managed entity) and any physician, regardless of the form or structure of such arrangement. The term "physician compensation arrangement" is to be construed broadly and includes, without limitation, the following categories of arrangements:
1. W-2 Physician Employment Agreements. All employment agreements between AHT and physicians employed by the Company on a full-time, part-time, or per-diem basis. As of the effective date of this Policy, AHT employs approximately 147 physicians under W-2 employment agreements across its 23 clinic locations.
2. Independent Contractor Physician Agreements. All independent contractor agreements between AHT and physicians providing clinical, administrative, supervisory, or other services on a contract basis. As of the effective date of this Policy, AHT maintains approximately 38 independent contractor physician arrangements, including medical director agreements.
3. Legacy Lakeview Medical Associates Arrangements. All physician compensation arrangements originally entered into by Lakeview Medical Associates, P.C. and assumed by AHT in connection with the August 15, 2022 asset acquisition of Lakeview Medical Associates, P.C. (aggregate purchase price: $11.4 million). These include 14 employment agreements (12 employment and 2 independent contractor) and 3 medical director agreements (with annual stipends of $45,000, $60,000, and $72,000, respectively). These legacy arrangements are subject to heightened scrutiny under this Policy due to the compliance gaps identified in the Calderwood & Harkness self-assessment.
4. ConnectiCare Physicians Network Arrangements. Any physician compensation arrangements entered into through ConnectiCare Physicians Network, LLC, or otherwise involving AHT-managed practices operating under the ConnectiCare brand or management services agreement structure.
5. On-Call Arrangements. All arrangements under which AHT compensates physicians for on-call coverage, whether through fixed stipends, per-call payments, or other compensation methodologies.
6. Teaching and Supervision Stipends. All arrangements under which AHT compensates physicians for teaching, mentoring, precepting, or supervising medical students, residents, fellows, or other trainees.
7. Administrative Compensation. All arrangements under which AHT compensates physicians for administrative duties, committee participation, utilization review, peer review, credentialing, or other non-clinical activities.
8. Productivity Bonuses and Quality Incentive Compensation. All productivity-based bonus structures, quality incentive payments, and value-based payment arrangements, including without limitation the Covenant Health Plans Inc. value-based incentive bonus program, under which AHT physicians received aggregate incentive payments of approximately $2.1 million in fiscal year 2022.
9. Medical Directorship Agreements. All agreements under which AHT compensates physicians for serving as medical directors of AHT clinics, departments, service lines, or programs, including arrangements across all 23 clinic locations.
10. DHS Referral Source Arrangements. Any arrangement with a physician (or an immediate family member of a physician, as defined in Section II.E below) who refers, or may refer, patients to AHT or its affiliates for designated health services ("DHS") payable by Medicare, Medicaid, or any other federal healthcare program. Given that AHT provides in-office laboratory services, diagnostic imaging services, and physical therapy services — all of which constitute DHS — virtually all physician compensation arrangements maintained by AHT are within the scope of this provision.
This Policy applies regardless of whether the physician compensation arrangement involves Medicare or Medicaid patients, because (a) the Massachusetts anti-kickback statute (M.G.L. c. 175H, § 3) applies to all-payer arrangements, and (b) as a matter of corporate policy, AHT requires FMV and commercial reasonableness compliance for all physician compensation arrangements.
C. Scope — Covered Personnel and Offices
This Policy applies to, and must be understood and followed by, all individuals involved in the initiation, negotiation, approval, administration, or oversight of physician compensation arrangements at AHT. Without limitation, the following individuals and offices are subject to this Policy:
1. Executive Officers. The Chief Executive Officer (Dr. Nathan Ellsworth), General Counsel (Patricia Yamamoto), Chief Compliance Officer (Derek Huang), Chief Financial Officer, and Chief Medical Officer.
2. Regional Medical Directors. All regional medical directors, including Dr. Vivian Chao (Regional Medical Director, Central Massachusetts), who are responsible for physician oversight and, in many cases, are themselves parties to physician compensation arrangements subject to this Policy.
3. Administrative and Operational Personnel. All individuals involved in physician recruitment, compensation negotiation, contracting, credentialing, or human resources functions, including clinic administrators, regional operations directors, and recruitment coordinators.
4. Board Compliance Committee Members. All members of the Board Compliance Committee, including the Ridgeline Capital Advisors LLC board designees: Claudia Sorrento (Managing Director) and Marcus Whitmore (Principal). The Board Compliance Committee exercises oversight authority over AHT's compliance program, including physician compensation compliance, and its members must be familiar with the standards set forth in this Policy.
5. External Advisors. Calderwood & Harkness LLP (outside regulatory counsel), Northbridge Valuation Advisors LLC (independent valuation firm), and Halsted Accounting Group LLP (external auditor) each play defined roles in the physician compensation compliance framework and are expected to operate consistently with the standards set forth herein.
II. DEFINITIONS
For purposes of this Policy, the following terms shall have the meanings set forth below. Capitalized terms used in this Policy and not otherwise defined herein shall have the meanings ascribed to them in the Revised AHT Compliance Program Manual (AHT-COMPL-2023-001) or, where applicable, the meanings set forth in the relevant statutory or regulatory provisions.
A. Fair Market Value (FMV)
"Fair Market Value" or "FMV" means the value in arm's-length transactions, consistent with the general market value of the subject transaction, as that term is defined in 42 C.F.R. § 411.351. Specifically, FMV for purposes of physician compensation means the compensation that would be paid in an arm's-length transaction between a willing buyer and a willing seller, neither being under compulsion to buy or sell and both having reasonable knowledge of the relevant facts.
For purposes of this Policy, FMV must be determined in accordance with the following principles:
• General Market Value vs. Specific Market Value. The determination of FMV must consider both the general market value for the type of physician services at issue (i.e., what similarly qualified physicians in the same specialty and geographic area are typically compensated) and the market value for the specific services to be performed under the arrangement (i.e., the particular scope, complexity, and volume of services involved).
• Referral-Neutral Valuation. FMV must be assessed without taking into account the volume or value of referrals or other business generated between the parties. This principle is foundational to both the Stark Law and the AKS, and any FMV analysis that explicitly or implicitly incorporates referral value is non-compliant.
• Contemporaneous Assessment. FMV must be assessed at the time the arrangement is entered into, at the time of each renewal or material amendment, and at each annual recertification, using the most current benchmark data and valuation methodologies available.
B. Commercial Reasonableness
"Commercial Reasonableness" means, consistent with CMS guidance and the definition codified in the Stark Law Modernization Final Rule (42 C.F.R. § 411.351, as amended effective January 19, 2021), an arrangement that furthers a legitimate business purpose of the parties to the arrangement and is on terms and conditions that are sensible, considering the particular circumstances of the parties, and that similar parties would agree to in an arm's-length transaction.
The following principles govern the determination of commercial reasonableness under this Policy:
• An arrangement may be commercially reasonable even if it does not result in profit for the entity, provided that it serves a legitimate, identifiable business need that is independent of the volume or value of referrals. For example, a medical directorship arrangement may be commercially reasonable even if it is not directly revenue-generating, if the medical director performs genuine oversight, quality improvement, or regulatory compliance functions that serve an operational need of the organization.
• An arrangement is not commercially reasonable if its primary or sole purpose is to secure or reward referrals, or if it cannot be justified by reference to a legitimate business need independent of the referral relationship between the parties.
• The commercial reasonableness analysis is distinct from, and complementary to, the FMV analysis. An arrangement may be at FMV but not commercially reasonable (e.g., if there is no genuine need for the services), and an arrangement may be commercially reasonable but not at FMV (e.g., if the compensation is above-market for the services performed). Both requirements must be independently satisfied.
C. Designated Health Services (DHS)
"Designated Health Services" or "DHS" means the categories of healthcare services identified in 42 U.S.C. § 1395nn(h)(6) to which the Stark Law's self-referral prohibition applies. The DHS categories are:
1. Clinical laboratory services
2. Physical therapy, occupational therapy, and outpatient speech-language pathology services
3. Radiology and certain other imaging services (including MRI, CT, and ultrasound)
4. Radiation therapy services and supplies
5. Durable medical equipment and supplies
6. Parenteral and enteral nutrients, equipment, and supplies
7. Prosthetics, orthotics, and prosthetic devices and supplies
8. Home health services
9. Outpatient prescription drugs
10. Inpatient and outpatient hospital services
AHT DHS Provision. AHT currently provides in-office clinical laboratory services, diagnostic imaging services (including X-ray and ultrasound), and physical therapy services at multiple clinic locations. All of these services constitute DHS under the Stark Law. Accordingly, compensation arrangements with physicians who refer patients for these services at AHT clinics are subject to the Stark Law's self-referral prohibition and must satisfy an applicable exception.
D. Referral Source
"Referral Source" means any physician (or immediate family member of a physician, as defined in Section II.E below) who is in a position to refer patients to AHT, or to order or generate business involving items or services payable by Medicare, Medicaid, or any other federal healthcare program. For purposes of this Policy, a physician is considered a Referral Source if he or she has referred, currently refers, or may in the future refer patients for DHS furnished by AHT or any AHT-affiliated entity.
Given the breadth of AHT's clinical operations and the in-house provision of DHS at its 23 clinic locations, virtually all physicians with whom AHT maintains compensation arrangements are Referral Sources for purposes of this Policy.
Revenue Context. AHT's fiscal year 2022 Medicare and Medicaid revenue constituted approximately 61% of the Company's $214.3 million in net revenue, equating to approximately $130.7 million. The magnitude of AHT's federal healthcare program revenue underscores the critical importance of ensuring that all physician compensation arrangements comply with the Stark Law and the AKS.
E. Immediate Family Member
"Immediate Family Member" has the meaning set forth in 42 C.F.R. § 411.351 and includes a physician's spouse (including common-law spouse), child, stepchild, parent, stepparent, sibling, stepsibling, grandparent, grandchild, son-in-law, daughter-in-law, father-in-law, mother-in-law, brother-in-law, and sister-in-law.
Specific Relevance. Dr. Karen Ellsworth, the spouse of AHT Chief Executive Officer Dr. Nathan Ellsworth, holds a 4.2% passive equity interest in Pinnacle Laboratory Services Inc. (EIN: 05-6138290; principal office: 1200 Warwick Avenue, Suite 110, Warwick, RI 02886). Pinnacle Laboratory Services Inc. receives approximately $1.65 million in annual referrals from AHT clinics in Rhode Island and southeastern Massachusetts. Because Dr. Karen Ellsworth is an immediate family member of Dr. Nathan Ellsworth, any compensation arrangements, referral relationships, or business transactions intersecting with the Pinnacle relationship require heightened FMV scrutiny and analysis under the Stark Law ownership/investment interest exceptions and AKS safe harbors. (See Section X for conflict of interest and related-party disclosure requirements.)
F. Additional Defined Terms
For purposes of this Policy, the following additional terms shall have the meanings set forth below:
"Benchmark Data" means physician compensation survey data published by nationally recognized survey organizations, including MGMA DataDive Provider Compensation and SullivanCotter Physician Compensation and Productivity Survey, as well as comparable data from other recognized sources approved by the Compensation Committee.
"Compensation Committee" means the standing committee established under Section VI.E of this Policy, responsible for reviewing and approving physician compensation arrangements in accordance with the approval workflows set forth herein.
"Compensation Package" means the aggregate value of all forms of remuneration provided to a physician under a compensation arrangement, including base salary, productivity bonuses, quality incentive payments, medical director stipends, benefits, perquisites, and any other form of consideration.
"Independent Valuation" means a fair market value opinion prepared by an independent, qualified valuation firm (currently Northbridge Valuation Advisors LLC) that has no financial interest in the outcome of the valuation and is not a party to, or beneficiary of, the arrangement being valued.
"Medical Director Arrangement" means any arrangement under which AHT compensates a physician for serving as the medical director of a clinic, department, service line, program, or other organizational unit, including arrangements involving clinical oversight, quality improvement, administrative supervision, and regulatory compliance functions.
"Productivity Compensation" means any component of physician compensation that is determined by reference to the volume of services personally performed by the physician, typically measured in work Relative Value Units ("wRVUs").
"Total Compensation" means the aggregate annualized value of all compensation and benefits provided to a physician under an arrangement, including base salary, productivity bonuses, quality incentive payments, medical director stipends, CME allowances, malpractice insurance premiums paid by AHT, retirement plan contributions, and the imputed value of any other benefits or perquisites.
"wRVU" or "work Relative Value Unit" means the work component of the relative value unit assigned to a physician service under the Medicare Physician Fee Schedule, as maintained by the Centers for Medicare & Medicaid Services ("CMS"). wRVUs are used to measure physician productivity for purposes of productivity-based compensation formulas.
III. REGULATORY FRAMEWORK
This Section summarizes the principal federal and state laws governing physician compensation arrangements and provides the regulatory context for the standards and procedures set forth in this Policy. All AHT personnel involved in physician compensation matters are expected to understand these legal requirements. This summary is not intended to be exhaustive; specific legal questions should be directed to General Counsel or Calderwood & Harkness LLP.
A. Federal Stark Law (42 U.S.C. § 1395nn)
1. Self-Referral Prohibition
The Stark Law prohibits a physician from making referrals for DHS payable by Medicare or Medicaid to an entity with which the physician (or an immediate family member of the physician) has a financial relationship, unless an applicable exception is satisfied. A "financial relationship" includes both ownership or investment interests and compensation arrangements. The Stark Law is a strict liability statute — no intent to violate the law is required. A referral that does not satisfy an exception results in a prohibition on billing for the referred services, and the entity that bills for such services faces liability for overpayment refunds, civil monetary penalties (up to $15,000 per service), treble damages, and potential exclusion from federal healthcare programs.
2. Key Exceptions Relevant to Physician Compensation
The Stark Law provides several exceptions that are directly relevant to AHT's physician compensation arrangements:
• Employment Exception (42 C.F.R. § 411.357(c)). Permits compensation paid by an employer to a physician who has a bona fide employment relationship with the employer, provided that the compensation is (i) paid for identifiable services, (ii) consistent with FMV for the services, (iii) not determined in a manner that takes into account the volume or value of referrals (except for certain productivity and value-based arrangements), and (iv) otherwise compliant with applicable law. This exception is the primary basis for AHT's W-2 physician employment agreements.
• Personal Services Exception (42 C.F.R. § 411.357(d)). Permits compensation paid under a personal services arrangement, provided that (i) the arrangement is set out in writing and signed by the parties, (ii) the arrangement covers all of the services to be provided, (iii) the aggregate services contracted for do not exceed those that are reasonable and necessary for the legitimate business purposes of the arrangement, (iv) the term of the arrangement is at least one year, (v) the compensation is set in advance and does not exceed FMV, and (vi) the compensation is not determined in a manner that takes into account the volume or value of referrals. This exception is the primary basis for AHT's independent contractor and medical director agreements.
• Fair Market Value Exception (42 C.F.R. § 411.357(l)). Permits compensation paid under an arrangement that satisfies certain requirements, including that the arrangement is in writing, the compensation is set in advance, consistent with FMV, and not determined in a manner that takes into account the volume or value of referrals. This exception may serve as an alternative basis for certain AHT arrangements.
• Indirect Compensation Arrangement Exception (42 C.F.R. § 411.357(p)). Applies where there is an unbroken chain of financial relationships between a physician and a DHS entity, but no direct compensation arrangement. This exception requires that the compensation received by the referring physician is FMV and is not determined in a manner that takes into account the volume or value of referrals.
3. Cross-Cutting Requirements
All Stark Law exceptions applicable to physician compensation share several common requirements that are central to this Policy:
• Compensation must be consistent with FMV.
• Compensation must not be determined in a manner that takes into account the volume or value of referrals for DHS.
• The arrangement must be in writing and signed by the parties.
• The compensation must be for specified services, and the services must be set forth with specificity in the written agreement.
• Compensation must generally be set in advance for the term of the arrangement.
These cross-cutting requirements are incorporated throughout the standards set forth in this Policy and in the revised contract templates prepared by Calderwood & Harkness LLP.
B. Federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b))
1. Prohibition on Remuneration to Induce Referrals
The AKS prohibits the knowing and willful offer, payment, solicitation, or receipt of any remuneration (including any kickback, bribe, or rebate) directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward the referral of patients for, or the purchasing, leasing, ordering, or arranging for or recommending purchasing, leasing, or ordering of, any item or service payable by a federal healthcare program. Unlike the Stark Law, the AKS is an intent-based criminal statute, though violations may also give rise to civil monetary penalties and False Claims Act liability.
2. Key Safe Harbors
The AKS provides regulatory safe harbors that, if fully satisfied, protect an arrangement from prosecution under the statute. The safe harbors most relevant to AHT's physician compensation arrangements include:
• Employment Safe Harbor (42 C.F.R. § 1001.952(i)). Protects amounts paid by an employer to a bona fide employee for employment in the provision of covered items or services, provided that the employment relationship is bona fide and the compensation is consistent with FMV.
• Personal Services and Management Contracts Safe Harbor (42 C.F.R. § 1001.952(d)). Protects payments made under a personal services or management contract, provided that (i) the agreement is in writing and signed by the parties, (ii) the agreement covers all services to be provided, (iii) the aggregate services do not exceed those reasonably necessary to accomplish the commercially reasonable business purpose of the services, (iv) the term is at least one year, (v) the compensation is set in advance, consistent with FMV, and not determined in a manner that takes into account the volume or value of referrals, and (vi) the services do not involve counseling or promotion of a business arrangement that violates any law.
All safe harbors require that aggregate compensation be set in advance, consistent with FMV, and not determined in a manner that takes into account the volume or value of referrals or other business generated between the parties (except as otherwise expressly permitted under the AKS Safe Harbor Modernization Final Rule for certain value-based arrangements).
C. State Law Requirements
1. Massachusetts Anti-Kickback Law
Massachusetts General Laws Chapter 175H, Section 3 (M.G.L. c. 175H, § 3) prohibits the payment or acceptance of any fee, kickback, or consideration for the referral of patients. Critically, unlike the federal AKS, the Massachusetts anti-kickback statute applies to all-payer arrangements — not only to patients covered by federal healthcare programs. This means that physician compensation arrangements at AHT's 14 Massachusetts clinics must satisfy FMV and anti-kickback requirements regardless of the payer source. The broader reach of this state statute reinforces the importance of applying the FMV and commercial reasonableness standards set forth in this Policy uniformly across all arrangements, without distinction based on payer mix.
2. Connecticut Referral Fee Prohibition
Connecticut General Statutes Section 20-7a(d) (Conn. Gen. Stat. § 20-7a(d)) prohibits physicians and other healthcare providers from paying or receiving compensation for the referral of patients. This prohibition applies to AHT's 4 Connecticut clinics and to physician compensation arrangements entered into through ConnectiCare Physicians Network, LLC or under the ConnectiCare managed services agreement structure. All physician compensation arrangements involving Connecticut-based physicians or clinics must be structured to avoid any compensation that could be characterized as a referral fee under this statute.
3. Rhode Island and New Hampshire
While Rhode Island and New Hampshire do not have state anti-kickback statutes that are as expansive as the Massachusetts statute, physician compensation arrangements at AHT's clinics in those states remain subject to the federal Stark Law and AKS requirements. AHT applies the same FMV and commercial reasonableness standards to arrangements in all four states as a matter of corporate policy.
D. OIG Compliance Guidance
The Office of Inspector General of the U.S. Department of Health and Human Services ("OIG") has published Compliance Guidance for Individual and Small Group Physician Practices (65 Fed. Reg. 59434, October 5, 2000), which emphasizes the importance of documented, transparent compensation-setting processes. While AHT is not a small physician practice, the OIG's guidance is instructive and reflects the expectations of federal enforcement authorities regarding physician compensation compliance. The OIG has consistently emphasized the following principles, which are incorporated into this Policy:
• Compensation arrangements with physicians should be documented in writing.
• Compensation should be consistent with FMV as determined through an objective, verifiable process.
• Compensation should not be determined in a manner that takes into account the volume or value of referrals.
• Organizations should maintain robust compliance programs that include physician compensation monitoring and auditing.
Additionally, AHT personnel should be aware that the OIG has issued numerous advisory opinions and fraud alerts addressing physician compensation arrangements, including OIG Special Fraud Alert: Physician Compensation Arrangements May Result in Significant Liability (June 9, 2021), which highlighted enforcement risks associated with above-FMV physician compensation, medical directorship arrangements with inflated stipends relative to documented hours, and compensation arrangements that correlate with referral patterns.
IV. APPROVED BENCHMARK SOURCES AND VALUATION METHODOLOGY
A. Primary Benchmark Sources
AHT utilizes the following primary benchmark sources for the assessment and validation of physician compensation FMV. These sources have been selected based on their national recognition, methodological rigor, data breadth, and acceptance by federal enforcement authorities and courts as reliable indicators of FMV for physician compensation.
1. Independent Third-Party Fair Market Value Opinions — Northbridge Valuation Advisors LLC
Northbridge Valuation Advisors LLC ("Northbridge") serves as AHT's primary independent valuation firm for purposes of rendering FMV opinions on physician compensation arrangements. Northbridge was retained in February 2023 at the recommendation of Calderwood & Harkness LLP following the identification of significant FMV documentation gaps in the Grayson Whitaker & Associates LLP compliance gap assessment and the Calderwood & Harkness self-assessment engagement.
Northbridge is currently engaged to provide FMV opinions for 52 physician compensation arrangements, comprising all 38 independent contractor/medical director agreements plus 14 Lakeview Medical Associates legacy employment agreements. In addition, Northbridge is engaged to provide FMV opinions for 2 office lease arrangements and the Meridian Diagnostics facility access fee.
Northbridge FMV opinions are required for all physician compensation arrangements where (a) total compensation exceeds the 75th percentile of applicable benchmark data, (b) the arrangement involves a medical director or independent contractor (regardless of percentile positioning), or (c) internal benchmark data diverges from external survey data by more than 10%. Northbridge opinions must be refreshed at least annually or upon any material amendment to the arrangement.
2. MGMA DataDive Provider Compensation Data
The Medical Group Management Association ("MGMA") DataDive Provider Compensation data set is a nationally recognized survey of physician compensation that provides compensation benchmarks by specialty, geographic region, practice type, and percentile ranking. MGMA data is widely used in the healthcare industry and is accepted by CMS, the OIG, and courts as a reliable source for physician compensation FMV benchmarking.
AHT uses the current edition of the MGMA DataDive Provider Compensation data for benchmarking employment compensation (base salary, total compensation, wRVU compensation), productivity compensation (wRVU conversion factors), and medical director stipends. The applicable MGMA data filters (specialty, geographic region — New England or Eastern region, practice setting — multispecialty group or single-specialty group) must be documented in each FMV analysis.
3. SullivanCotter Physician Compensation and Productivity Survey
The SullivanCotter Physician Compensation and Productivity Survey is a nationally recognized supplemental benchmark source that provides physician compensation data by specialty, organizational type, and geographic region. AHT uses SullivanCotter data as a supplemental or confirmatory benchmark source, particularly for specialty-specific compensation analyses and for medical director compensation where MGMA data alone may be insufficient.
Where MGMA and SullivanCotter data yield materially different FMV ranges for a particular arrangement, the more conservative range should generally be applied, or an independent Northbridge FMV opinion should be obtained to reconcile the difference.
B. Acceptable Valuation Methodologies
FMV determinations for physician compensation arrangements may be conducted using one or more of the following generally accepted valuation methodologies, depending on the nature of the arrangement:
1. Market Approach. The market approach determines FMV by reference to comparable arm's-length transactions in the relevant market. For physician compensation, this typically involves comparison to physician compensation survey data (MGMA, SullivanCotter) for the applicable specialty, geographic region, and practice type. The market approach is the most commonly used methodology for physician employment and independent contractor compensation and is generally the preferred methodology under this Policy.
2. Income Approach. The income approach determines FMV based on the economic benefit that the arrangement is expected to generate. For physician compensation, this may involve a discounted cash flow analysis or a productivity-based analysis that correlates compensation to the revenue or value generated by the physician's personally performed services. The income approach must be used with caution to ensure that it does not directly or indirectly incorporate the value of referrals for DHS.
3. Cost Approach. The cost approach determines FMV based on the cost of replacing the services to be performed. For physician compensation, the cost approach is most commonly applied using a time-and-effort methodology, particularly for medical director and administrative service arrangements, where the FMV is calculated based on the number of hours required to perform the duties multiplied by an appropriate hourly rate. The cost approach is the preferred methodology for medical director arrangements under this Policy.
4. Hybrid Approaches. In some cases, a combination of market, income, and cost approaches may be appropriate. For example, a medical director arrangement may be valued using a cost approach (time-and-effort methodology) with the hourly rate validated against market approach data (MGMA/SullivanCotter medical director compensation surveys).
Referral Exclusion. Regardless of the methodology used, FMV valuations must not reflect, incorporate, or be influenced by the volume or value of anticipated referrals between the parties. Any valuation that explicitly or implicitly takes referral volume into account is non-compliant with the Stark Law, the AKS, and this Policy.
C. Current AHT Compensation Benchmarks (Reference Data Points)
The following reference data points reflect AHT's current physician compensation levels as of the effective date of this Policy. These data points are provided for informational and benchmarking purposes and will be updated annually upon completion of each recertification cycle (see Section IX).
Calculation of Effective Average Medical Director Hourly Rate:
$1,920,000 ÷ (38 arrangements × 8.4 hours/month × 12 months) = $1,920,000 ÷ 3,830.4 hours = $501.28/hour
Critical Finding. The effective average medical director hourly rate of $501.28/hour has been flagged as exceeding the 90th percentile for multiple specialties per both MGMA and SullivanCotter benchmark data. This finding was identified in both the Grayson Whitaker compliance gap assessment and the Calderwood & Harkness self-assessment and constitutes a significant compliance deficiency requiring immediate remediation. The remediation plan is set forth in Section VIII of this Policy.
D. Limitations on Internal Benchmarking
AHT personnel should understand that internal benchmarking — i.e., comparison of a proposed compensation arrangement to other AHT physician compensation arrangements — is by itself insufficient to establish FMV. Internal compensation data may reflect the same systemic deficiencies, above-market rates, or non-compliant structures that this Policy is designed to correct. Accordingly, the following limitations apply:
• Internal benchmarking may be used as a preliminary screening tool to identify arrangements that may warrant further analysis, but must always be validated against external survey data (MGMA, SullivanCotter) or an independent third-party FMV appraisal.
• When internal compensation data for a particular specialty or arrangement type diverges from external benchmark data by more than 10% (whether above or below the external benchmark median), an independent third-party FMV opinion from Northbridge Valuation Advisors LLC (or an equivalent qualified valuation firm approved by General Counsel) is required before the arrangement may be approved or renewed.
• In no event may the fact that other AHT physicians in the same specialty are compensated at a particular level be used as the sole justification for proposing compensation at that level for a new or renewed arrangement.
V. COMPENSATION STRUCTURE STANDARDS
A. Employed Physician Compensation (147 W-2 Physicians)
1. Base Salary
Base salary for employed physicians must be set within the FMV range for the physician's specialty, geographic region (New England), and experience level, as determined by reference to the approved benchmark sources described in Section IV.A. The base salary component of physician compensation is subject to the following requirements:
• Base salary must be expressed as a fixed annual amount, payable in regular installments (bi-weekly or semi-monthly), and documented in the written employment agreement.
• Base salary must be determined based on the physician's specialty, board certification status, years of experience, geographic market, and scope of clinical and administrative responsibilities, as supported by applicable benchmark data.
• Base salary must not be conditioned on, or vary with, the volume or value of the physician's referrals for DHS. A physician's base salary may not increase or decrease based on the number of patients referred for laboratory services, diagnostic imaging, physical therapy, or other DHS provided by AHT.
• Base salary must be set in advance for the term of the employment agreement. Adjustments to base salary may be made at the time of annual performance review or contract renewal, but must be documented in writing, supported by updated FMV analysis, and approved through the applicable workflow set forth in Section VI.
2. Productivity-Based Compensation
Productivity bonuses tied to personally performed services are a permissible component of employed physician compensation, subject to the following requirements:
• Productivity bonuses must be measured by work Relative Value Units ("wRVUs") attributable to services personally performed by the physician. The use of wRVUs as the productivity metric is consistent with the Stark Law employment exception, which permits productivity bonuses that do not directly take into account the volume or value of referrals.
• The wRVU conversion factor (dollars per wRVU) used to calculate productivity bonuses must fall within the FMV range established by Northbridge Valuation Advisors or validated against the MGMA and SullivanCotter median-to-75th-percentile range for the physician's specialty and geographic region. Conversion factors that exceed the 75th percentile require independent FMV justification.
• Productivity compensation formulas must be set in advance for the term of the employment agreement and documented in writing as part of the compensation methodology appendix to the agreement. The formula, including the applicable wRVU thresholds, conversion factor, and any caps or tiers, must be specified with sufficient detail that the physician's productivity bonus can be calculated objectively based on reported wRVU data.
• Productivity compensation must be based solely on services personally performed by the physician and may not include wRVUs generated by referrals to other AHT providers, "incident-to" services performed by non-physician staff, or services performed by other members of a physician's care team (except to the extent such services are properly attributed to the physician under applicable billing rules).
3. Quality and Value-Based Incentive Compensation
Bonuses tied to quality metrics, patient satisfaction scores, or value-based care objectives are a permissible component of employed physician compensation, provided they are structured to comply with the following requirements:
• Quality and value-based incentive bonuses must be tied to bona fide, objective, and measurable quality metrics or value-based care objectives. Examples of permissible metrics include patient satisfaction scores (e.g., Press Ganey or CG-CAHPS), clinical quality measures (e.g., HEDIS measures, preventive care compliance rates), care coordination metrics, and cost efficiency measures.
• Quality and value-based incentive bonuses must not serve as proxies for referral volume. A bonus structure that is nominally tied to a "quality" metric but in practice rewards physicians based on the volume of referrals for DHS is non-compliant with the Stark Law and the AKS.
• Arrangements under value-based enterprise ("VBE") frameworks, including the Covenant Health Plans Inc. value-based incentive bonus program, must satisfy the Stark Law value-based enterprise exceptions under the 2021 Modernization Final Rule (42 C.F.R. § 411.357(aa)). Covenant Health Plans Inc. is AHT's largest commercial payer, representing approximately $38.6 million (18%) of AHT's $214.3 million net revenue in fiscal year 2022. The Covenant VBE incentive bonuses, which totaled approximately $2.1 million in aggregate across AHT physicians in fiscal year 2022, must be analyzed for compliance with the applicable VBE exception requirements, including the requirements that (i) the arrangement is between VBE participants in a value-based arrangement, (ii) the compensation is for or results from value-based activities, and (iii) the compensation is not determined in a manner that directly takes into account the volume or value of referrals.
• Quality metrics must be documented in writing as part of the employment agreement or a written addendum, and the methodology for calculating quality bonuses must be set forth with sufficient specificity to allow objective determination. Quality metric results must be maintained and available for audit.
4. Benefits and Perquisites
The value of benefits and perquisites provided to employed physicians is included in the total compensation analysis for FMV purposes. Accordingly, the following standards apply:
• Standard employer-provided benefits, including health insurance, dental and vision coverage, retirement plan contributions (401(k) match or defined contribution), continuing medical education ("CME") allowances, paid time off, and professional liability (malpractice) insurance coverage, must be included in the calculation of total compensation for benchmarking purposes.
• Aggregate total compensation — defined as the sum of base salary, productivity bonuses, quality incentive bonuses, and the imputed value of all benefits and perquisites — must not exceed FMV for the physician's specialty and geographic region. This analysis must be performed at the time of initial approval, at each renewal, and at each annual recertification.
• Non-standard benefits or perquisites (e.g., signing bonuses, relocation allowances, student loan repayment, housing stipends, automobile allowances) must be specifically documented, included in the total compensation analysis, and approved through the applicable workflow set forth in Section VI.
B. Independent Contractor Physician Compensation (38 Arrangements)
1. Fixed Compensation Requirement
All independent contractor and medical director compensation must be structured as a fixed amount, set in advance, and must not vary based on the volume or value of referrals. This requirement is fundamental to satisfying both the Stark Law personal services exception and the AKS personal services and management contracts safe harbor. Specifically:
• Compensation must be expressed as a fixed annual stipend, a fixed monthly payment, or a fixed per-service rate (where per-service compensation is appropriate), and must be specified in the written agreement.
• Per-service or variable-rate compensation structures are disfavored and are permitted only when they can be structured to satisfy the applicable safe harbor requirements — specifically, that aggregate compensation is set in advance, the services are specified, and the compensation is consistent with FMV. Variable-rate structures must be reviewed and approved by General Counsel before execution.
• Compensation must not include any component that is contingent upon, correlated with, or adjusted based on the volume or value of the physician's referrals for DHS or other items or services payable by federal healthcare programs.
2. Specification of Services and Hours
Each independent contractor and medical director agreement must specify with particularity the services to be performed and the time commitment expected:
• The agreement must describe the exact nature of the duties to be performed, categorized by type (e.g., clinical services, administrative oversight, quality improvement, committee participation, regulatory compliance, staff training and supervision, protocol development).
• The agreement must specify the minimum and maximum expected hours per week or per month, and must identify the clinic location(s) or department(s) where services will be performed.
• The level of specificity must be sufficient to demonstrate that the arrangement serves a legitimate, identifiable business purpose and that the compensation is commensurate with the scope and complexity of the duties described.
• Contemporaneous time logs must be maintained by all medical directors and independent contractors in accordance with the requirements set forth in Section VII.C below.
3. Medical Director Arrangements — Specific Standards
Medical directorship arrangements present particular compliance risk due to the potential for inflated compensation, vague duty descriptions, and insufficient documentation of hours actually worked. The Calderwood & Harkness self-assessment and the Grayson Whitaker gap assessment both identified significant deficiencies in AHT's medical director compensation practices. Accordingly, the following specific standards apply to all medical director arrangements:
FMV Validation of Hourly Rate. Medical director stipends must reflect FMV for the time actually required and the services actually rendered. To ensure compliance, the effective hourly rate for each medical director arrangement must be calculated by dividing the annual stipend by the total annual hours reported on time logs. The resulting hourly rate must be validated against specialty-specific benchmark data from MGMA and SullivanCotter for medical director or administrative services compensation.
Current Deficiency. As documented in Section IV.C, the effective average hourly rate across AHT's 38 medical director arrangements is $501.28 per hour. This rate exceeds the 90th percentile for medical director compensation across multiple specialties and does not satisfy FMV requirements absent documented justification supported by an independent FMV opinion.
Remediation Requirement. All medical director arrangements must be restructured so that either:
(a) Compensation is reduced to fall within the 50th-to-75th percentile FMV range for the applicable specialty and geographic region, as determined by Northbridge Valuation Advisors or equivalent qualified valuation firm; or
(b) Documented hours are increased commensurate with the compensation paid, such that the effective hourly rate falls within the FMV range, supported by a Northbridge FMV opinion confirming that the increased hours and expanded duties are commercially reasonable; or
(c) A combination of compensation reduction and hours increase is implemented to achieve compliant alignment.
In all cases, the restructured arrangement must be supported by an individual Northbridge FMV opinion, a revised written agreement using the Calderwood & Harkness medical director agreement template, and updated duty descriptions. The remediation timeline is set forth in Section VIII.
Standardized Duty Descriptions. Medical director duty descriptions must be standardized across the organization, developed for each clinical area and clinic location, and must be sufficiently specific to demonstrate that the medical directorship serves a legitimate business purpose independent of the physician's referral activity. Generic or boilerplate duty descriptions that do not reflect the actual operational needs of the clinic or department are insufficient.
C. Legacy Lakeview Medical Associates Arrangements
The 14 physician agreements (12 employment agreements and 2 independent contractor agreements) and 3 medical director agreements (with annual stipends of $45,000, $60,000, and $72,000) assumed by AHT in the August 15, 2022 acquisition of Lakeview Medical Associates, P.C. (aggregate purchase price: $11.4 million) must be brought into full compliance with this Policy within 90 days of the Policy effective date (i.e., by October 13, 2023).
The Calderwood & Harkness self-assessment identified the following specific deficiencies in the Lakeview legacy arrangements:
• Multiple employment agreements lacked documented FMV substantiation at the time of original execution and were not re-evaluated for FMV compliance at the time of the AHT acquisition.